InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Hamm John M., Chief Financial Officer. Officer active across 1 companies, notably Cumberland Pharmaceuticals INC. Aggregated, 3 reports have been logged. Total volume traded: €16k. The latest transaction was filed on 16 March 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€47,22220,000 shares@ €2.36110.058% mcap74.8% of flow
Common Stock
SEC:0001209191-22-026140:0·
€7,9433,800 shares@ €2.09030.0097% mcap100.0% of flow
Common Stock
SEC:0001209191-21-067905·
Ideal exit: 20 Aug 2022 (T+270)
€7,9433,800 shares@ €2.09030.0097% mcap12.6% of flow
Common Stock
SEC:0001209191-21-067905:0·
Ideal exit: 20 Aug 2022 (T+270)
3 of 3 declarations
About Hamm John M.
John M. Hamm is the Chief Financial Officer of CUMBERLAND PHARMACEUTICALS INC. He is responsible for the financial management of the company, including financial planning and financial reporting. Hamm plays a crucial role in Cumberland Pharmaceuticals' financial strategy, contributing to its stability and growth.
